Diffuse esophageal spasm, an uncommon esophageal motility disorder, has recently been defined using high-resolution manometry. Patients with distal esophageal spasm usually complain of chest pain or dysphagia. The etiology and pathophysiology of this disorder are poorly known, and treatment options are limited. However, some options to improve symptoms are available, including endoscopic injection of botulinum toxin. Nevertheless, few reports have described the effects of endoscopic injection of botulinum toxin in patients with symptomatic diffuse esophageal spasm with clear endoscopic and high-resolution manometry images. Here, we report a case of diffuse esophageal spasm diagnosed with high-resolution manometry and treated by endoscopic injection of botulinum toxin with good results at the 7-month follow-up. (Korean J Gastroenterol 2012;60:109-112) 
INTRODUCTION
Esophageal spasm (ES) is a rare esophageal motility disorder characterized by simultaneous esophageal contraction with intermittent peristalsis on conventional manometry. 1 Although the pathophysiology and etiology remain uncertain, the suggested pathophysiology of ES includes cholinergic, nitregic, and reflux mechanisms. 2 Patients with ES usually complain of dysphagia or chest pain, which are difficult to distinguish from angina pectoris. Many trials have reported the efficacy of pharmacological, endoscopic, and surgical therapies. Recent studies suggest a benefit of injecting botulinum toxin in the diffuse esophagus for treating symptomatic ES. 3 We report a case of a 69-year-old woman with manometrically proven symptomatic ES treated with intramuscular injection of botulinum toxin.
CASE REPORT
A 69-year-old woman with dysphagia and excessive vomiting was admitted to our hospital. She felt chest discomfort while swallowing solid or liquid food for several months. She was taking antihypertensive medicine and had a history of bronchial asthma. Radiographic examinations were done to rule out underlying diseases. There was no active lesion in her chest x-ray or on chest CT. The esophagogram showed repetitive, multifocal, and simultaneous contractions in the esophageal body (Fig. 1A) . She had no evidence of cardiac disease on electrocardiography. Esophagogastroduodenoscopy showed strong, repetitive contractions in the lower Initial esophagoscopy showed much impacted food in the esophageal lumen, which was not dilated fully during the observations. There was no stricture in the esophageal body or at the esophagogastric junction. Fig. 2 . High-resolution manometry showed rapid contractile front velocity (CFV) attributed to spasm (12 cm/sec) throughout the distal esophageal segments. showed significantly decreased tertiary contractions in the mid to distal esophagus, and contrast passed through the gastroesophageal junction smoothly without stasis (Fig. 3A) .
The clinical response was maintained for over 7 months with an improved total symptom score.
DISCUSSION
DES is a rare esophageal motility disorder found in patients with unexplained chest pain or dysphagia, accounting for about 3% of the motility abnormalities seen in such patients. 1 In Korea, DES is diagnosed in 0.9-2.2% of the patients with esophageal symptoms. 4, 5 Chest pain (46-47%) and dysphagia (27-41%) are the primary presenting symptoms in this population. 6 Some patients complain of globus (9-11%), acid regurgitation (9%), and indigestion (9%). Non-cardiac chest pain is often difficult to differentiate from cardiac angina, but the chest pain caused by the esophagus is non-radiating, is relieved by swallowing water, and is triggered by swallowing a large amount of solid or liquid food.
Although the mechanisms of non-cardiac chest pain are uncertain, some have been suggested, including the presence of acid reflux, esophageal motility abnormalities, and visceral hypersensitivity. 8, 9 Dysphagia for both liquid and solids occurs intermittently and is rarely progressive. The degree of dysphagia varies, and it is not always accompanied by chest pain. In this case, the patient's chief complaints were dysphagia, vomiting, and non-cardiac chest pain.
The pathogenesis of DES is unclear, but studies suggest Endoscopic injection of botulinum toxin into the LES is effective in the treatment of achalasia. 19 This method also showed good results in patients with severe DES. The symptoms in DES patients, which resist medical treatment, improved significantly after the endoscopic injection of botulinum toxin into the esophageal muscle, and the clinical response persisted for at least 6 to 12 months. Some patients with relapsed symptoms underwent repeated injection of botulinum toxin and were successfully retreated. 3 No further side effects have been reported in patients with achalasia or DES treated with botulinum toxin injection. 20 In the present case, we injected botulinum toxin endoscopically to treat symptomatic DES. After the injection, the esophageal symptoms were relieved, and the clinical response continued for over 7 months without repeated injection of botulinum.
